Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07314814) titled 'Genetic Hallmarks of Patients With Congenital Portosystemic Shunts and Portopulmonary Hypertension' on Dec. 18, 2025.

Study Type: Observational

Primary Sponsor: Prof. Valerie Mc Lin

Condition: Portopulmonary Hypertension Pulmonary Arterial Hypertension (PAH) Congenital Portosystemic Shunt

Intervention: Genetic: targeted gene panels analysis

Recruitment Status: Not recruiting

Date of First Enrollment: February 1, 2026

Target Sample Size: 120

Countries of Recruitment: Switzerland

To know more, visit https://clinicaltrials.gov/study/NCT07314814

Published by HT Digital Content Services with permission from H...